NanoViricides (NYSE:NNVC) Now Covered by

Equities research analysts at began coverage on shares of NanoViricides (NYSE:NNVCGet Rating) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.

NanoViricides Trading Up 3.7 %

Shares of NYSE:NNVC opened at $1.39 on Wednesday. The company has a 50 day moving average of $1.37 and a 200 day moving average of $1.64. The stock has a market cap of $16.18 million, a P/E ratio of -2.32 and a beta of 1.14. NanoViricides has a 12 month low of $1.04 and a 12 month high of $3.88.

About NanoViricides

(Get Rating)

NanoViricides, Inc is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R.

Further Reading

Receive News & Ratings for NanoViricides Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides and related companies with's FREE daily email newsletter.